Redirecting to https://www.wallstreet-online.de/nachricht/19904164-arrivent-presents-the-final-analysis-of-firmonertinib-monotherapy-data-from-global-phase-1b-study-egfr-pacc-mutant-non-small-cell-lung-cancer-at-the-2025-world-conference-on-lung-cancer